[Elsevier] Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): final analysis of a randomised, open-label, international, phase 3 study |
|
This post will be closed automatically in 2026-09-11 22:28
Reward25points
|
10
Nutritional, functional, and psychological considerations for incretin-based therapies in adults〞an EASO, EFAD, and ECPO Consensus Statement
10
[Other]Densification effect of perovskite-type Li3xLa2/3-xTiO3 solid-state electrolytes for energy storage applications
20
Artificial intelligence每driven oocyte assessment for predicting blastulation and high-quality blastocyst formation in severe male factor infertility
10
A Road Map for Addressing Incidental Findings in Pediatric Radiology
20
The hydrogen storage properties of TiFe0.85Mn0.05 alloys synthesized via sintering and melting routes
